24-month post marketing safety surveillance data of a novel continuous release and absorption melatonin (CRA-melatonin) delivery system, confirms favorable safety profile

Authors
Category Primary study
JournalSleep
Year 2020
This article has no abstract
Epistemonikos ID: 3324abfd1873ea87100c3b6385d977c0d1638338
First added on: Feb 12, 2025